ライフサイエンスコーパス: further complicate

1 notations were last updated is not apparent, further complicating a researchers' ability to assess th

2 challenge as the large size of these tumors further complicates an already difficult procedure.

3 tion patterns for many scaffolds is limited, further complicating analysis.

4 This further complicates annotation of metagenomic datasets,

5 f a different dosing regimen for RTX and OBZ further complicates any interpretation of clinical resul

6 vant even at small interaction angles and is further complicated at large angles by a non-conservatio

7 ization/sensitivity, and temperature optima, further complicating attempts to reconstruct the tree of

8 This definitional problem is further complicated because neither host nor microbial p

9 This situation has been further complicated because two other cryptic species fr

10 nconsistent, and comparing published data is further complicated by a lack of standard processing and

11 teroid therapy and whose clinical course was further complicated by acute tubular necrosis and renal

12 This situation is further complicated by changing the environmental condit

13 These tasks are further complicated by conflicting and proprietary image

14 The process is further complicated by effects arising from the intracel

15 ation sites with tandem mass spectrometry is further complicated by fragmentation of both the peptide

16 nction in pregnancy, and 2%-12% of cases are further complicated by hemolysis (H), elevated liver tes

17 Interpretation of these effect estimates is further complicated by heterogeneity (variation, modific

18 illus Calmette-Guerin therapy is complex and further complicated by high numbers of patients who are

19 The effect of exercise in obese women was further complicated by insurance status.

20 In diffusion MRI, this is further complicated by intra-voxel inter-subject differe

21 Thalassemia may be further complicated by iron overload (frequently exacerb

22 the wing movements of a flying butterfly and further complicated by its motion in and out of shadows.

23 y (DCM), but the technique is subjective and further complicated by left bundle-branch block (LBBB).

24 This is further complicated by our finding that bivalent LRP6 an

25 The transfection experiment is further complicated by PCR errors and the presence of vi

26 f varicella-zoster virus exposure and can be further complicated by postherpetic neuralgia.

27 This is further complicated by societal factors that receive ext

28 Assessing the effect of PEG is further complicated by the aggressively fatal disease, s

29 counterion and water distribution, which is further complicated by the approach and binding of a pro

30 Decision-making is further complicated by the choice of an invasive (aggres

31 therapies for neurodegenerative diseases is further complicated by the difficulty in determining whe

32 This is further complicated by the dynamics in runoff flows and

33 reover, this somewhat simplistic division is further complicated by the existence of both ectoparasit

34 asis evolved and this simplistic division is further complicated by the existence of both ectoparasit

35 The situation is further complicated by the existence of six mammalian im

36 This situation is further complicated by the existence of their multiple s

37 This decision is further complicated by the fact that a phase III study d

38 This problem is further complicated by the fact that an intrinsic charac

39 This is further complicated by the fact that datasets obtained w

40 These diversities are further complicated by the fact that OSA/PSA spontaneous

41 The unreliable variance estimation is further complicated by the fact that the technology-spec

42 Early diagnosis is further complicated by the fact that there are likely ma

43 This situation has been further complicated by the fact that two other cytokines

44 y to analyze large numbers of mutants and is further complicated by the high rate of cointegration of

45 ghly non-linear and dynamic nature, which is further complicated by the issue of non-identifiability.

46 tion of ribonucleotides for DNA synthesis is further complicated by the lack of a ribonucleotide redu

47 t for attribution and provenance studies, is further complicated by the low concentrations at which t

48 roduces a complex regulatory picture that is further complicated by the multiple intracellular locati

49 d upon laborious germline targeting, and are further complicated by the need to avoid developmental p

50 This was further complicated by the observation that changes in t

51 Their use is further complicated by the observation that many patient

52 terpretations of amygdala lesion studies are further complicated by the potentially confounded nature

53 This gets further complicated by the presence of biophysical facto

54 nd selection of antiepileptic drugs is often further complicated by the presence of comorbidities, po

55 Such analysis is further complicated by the presence of hypervariable reg

56 such compounds by chemical synthesis can be further complicated by the presence of multiple nitrogen

57 The picture is further complicated by the presence of nonfunctional env

58 xpression during mouse development which was further complicated by the presence of several alternati

59 eous subvisible particle characterization is further complicated by the presence of silicone oil drop

60 This is further complicated by the prevalence of steatosis in ab

61 The second problem is further complicated by the reliance of separation in DQA

62 This is further complicated by the transcription-coupled incorpo

63 ers considerably between institutions and is further complicated by the transitional physiology of th

64 ing track of all these proteins, a situation further complicated by the variety of names and identifi

65 ing the individual roles of these factors is further complicated by their ability to cross-regulate o

66 This can be further complicated by transfusion, though the contribut

67 The structure is further complicated by twinning.

68 resistance is a major public health threat, further complicated by unexplained treatment failures ca

69 It is further complicated by variability in nonspecific identi

70 ticity of enzyme functions of these pathways further complicate correct annotation.

71 e availability of direct oral anticoagulants further complicates decision making and guidance here is

72 ontrasting effects on blood and brain levels further complicates drug dosing.

73 ation in the coreceptor binding domain could further complicate HIV-1 vaccine design.

74 However, the pharmacology of this series was further complicated in that certain analogs displaying o

75 This is further complicated in the presence of degradation produ

76 at constitutes elder abuse and neglect, this further complicates instrument development and clinical

77 gly important, while collisions and crowding further complicate inter-particle interactions.

78 e new tests into existing clinical care, and further complicates many of the economic and ethical dil

79 Further complicating matters, differences in life histor

80 ction, presents a new set of challenges that further complicate more traditional PCR setups.

81 laboratories or reproduced in animal models further complicates our understanding of psychiatric dis

82 Further complicating our grasp of these disorders are am

83 ticularly liver and kidney, is not uncommon, further complicating perioperative care.

84 asily in large quantity without resorting to further complicated purification.

85 but in the case of complex diseases this is further complicated since genetic factors in affected in

86 Organ dysfunction often further complicates such toxicities and may even be proh

87 oduce correlation among the samples and thus further complicate the analysis and interpretation of mi

88 These errors further complicate the automated identification of EST-r

89 ost patients with severe thalassaemia, might further complicate the clinical phenotype.

90 use, mental illness, and infectious disease further complicate the delivery of care.

91 i are an emerging threat to human health and further complicate the general problem of treating serio

92 pic effects between these two substrates can further complicate the metabolic profile of the enzyme.

93 lycaemia, weight gain, and drug interactions further complicate the treatment process.

94 iurnal variation, and regression to the mean further complicate the understanding of whether monocula

95 ex interplay of signal-transduction pathways further complicates the customization of cancer treatmen

96 ended haplotypes encompassing NCF-1/psiNCF-1 further complicates the detection of A47 degrees CGD car

97 standardized clinical or laboratory criteria further complicates the diagnosis and management.

98 ty of responses targeting different epitopes further complicates the discovery of determinants of pro

99 ventricular cardiomyocytes, skeletal muscle) further complicates the identification of optimal therap

100 Arbitrarily defining genotypes further complicates the interpretation of genotyping res

101 Metagenomics further complicates the issue by generating fragmented 1

102 pendence of streamflow trends on flow regime further complicates the issue.

103 uirement to filter noise from the raw signal further complicates the modeling process, as it limits t

104 ecules in all Archaea and in some eukaryotes further complicates the picture of translation initiatio

105 tain significance, often missense mutations, further complicates the risk assessment.

106 of a meaningful protein-encoding transcript further complicates the story.

107 allenge, the current lack of structural data further complicates the use of Gluc for in vitro applica

108 also affect the function of adjacent genes, further complicating the aetiology of the disease.

109 ltiple protein variants from the CASK locus, further complicating the interpretation of experiments u

110 thrombotic risk resides in many specialties, further complicating the issue.

111 Though further complicating the measuring procedure and the cor

112 Further complicating the process is the existence of pol

113 Further complicating the process, myosin binding acceler

114 at should be dealt with carefully to prevent further complicating the situation and should be resolve

115 acity to form stereoisomeric superstructures further complicating the study of this series of compoun

116 different, requirements for their training, further complicating the task of education.

117 eW binding surfaces near the receptor tip or further, complicating the events at this highly conserve

118 of beta-glucans, soluble versus particulate, further complicate their mechanism of action.

119 t RAF autoinhibition underpins this paradox, further complicating therapeutic strategies centered aro

120 cation decision is made; commercial bias may further complicate this balance.

121 However, emerging data appear set to further complicate this picture.

122 cules other than proteins present in tissues further complicate tissue proteomic analysis.

123 Variation unrelated to pathology further complicates transcriptomic, proteomic and metabo

124 Interpretations are further complicated when comparing different pepMHC, bec

125 Full-length HIV-1 RNA transport is further complicated when group-specific antigen (Gag) pr

126 The situation is further complicated when you consider that the genome is